Recently, Presneill et al. demonstrated that low-dose GM-CSF was associated with improved gas exchange without pulmonary neutrophil infiltration and was not associated with worsened acute respiratory distress syndrome or the multiple organ dysfunction syndromes in patients with sepsis-associated respiratory dysfunction [41]. This evidence concerns the gene CSF2 and Sepsis.